Skip to main content
SpringerLink
Log in

Zwischenfälle bei Chinidinbehandlung

  • Published:
Archiv für Kreislaufforschung Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Acierno, L. J. andR. Gubner, Utility and limitations of intravenous quinidine in arrhythmias. Amer. Heart J.41, 733 (1951).

    Article  PubMed  Google Scholar 

  2. Alimurung, M. M. andM. C. Chiaco, Aberrant ventricular conduction simulating paroxysmal ventricular tachycardia during quinidine therapy. Amer. Heart. J.52, 462 (1956).

    Article  PubMed  Google Scholar 

  3. Angelakos, E. T. andR. P. Hastings, The influence of quinidine and procaine amide on myocardial contractility in vivo. Amer. J. Cardiol.5, 791 (1960).

    Article  PubMed  Google Scholar 

  4. Archer, H. E., D. Weitzman andH. L. Kay, Control of quinidine dosage. Brit. Heart, J.17, 534 (1955).

    Google Scholar 

  5. Armbrust, C. A. andS. A. Levine, Paroxysmal ventricular tachycardia; a study of one hundred seven cases. Circulation1, 28 (1950).

    PubMed  Google Scholar 

  6. Armitage, A. K., The influence of potassium concentration on the action of quinidine and of some antimalarial substances on cardiac muscle. Brit. J. Pharmacol.12, 75 (1957).

    Google Scholar 

  7. Askey, J. M., Quinidine in the treatment of auricular fibrillation. Ann. Int. Med.24, 371 (1946).

    Google Scholar 

  8. Bailey, D. J., Cardiotoxic effects of quinidine and their treatment. Review and case reports. Arch. Int. Med.105, 13 (1960).

    Google Scholar 

  9. Bellet, S., G. Hamden, A. Somlyo andR. Lara, The reversal of the cardiotoxic effects of quinidine by molar sodium: An experimental study. Amer. J. Med. Sci.237, 165 (1959).

    PubMed  Google Scholar 

  10. Benthe, H. F., Beitrag zur Beurteilung der antifibrillären Eigenschaft des Chinidins und ähnlich wirkender Substanzen. Arch. exper. Path. Pharm.229, 82 (1956).

    Google Scholar 

  11. v. Bergmann, G., Zur Chinidintherapie des Herzens. Münch. Med. Wschr.66, 705 (1919).

    Google Scholar 

  12. Berley, B. A. andG. Saland, Febrile hypersensitivity to quinidine orally. J. Amer. Med. Ass.148, 1121 (1952).

    Google Scholar 

  13. Berman, R. andJ. S. Blumenthal, Quinidine in auricular fibrillation. Minnesota Med.25, 198 (1942).

    Google Scholar 

  14. Berman, R., C. M. Sadoff andG. Gordon, Quinidine intoxication occuring during treatment of auricular arrhythmias. Minnesota Med.36, 1052 (1953).

    PubMed  Google Scholar 

  15. Binder, M. J. andL. Rosove, Paroxysmal ventricular tachycardia and fibrillation due to quinidine. Amer. J. Med.12, 491 (1952).

    Article  PubMed  Google Scholar 

  16. Blinder, H., J. Burstein, W. Horowitz, E. Gersh andR. Smelin, Studies on the effect of parenteral quinidine administration. Arch. Int. Med.86, 917 (1950).

    Google Scholar 

  17. Boden, E. undP. Neukirch, Klinische und experimentelle Beobachtungen über die Herzwirkung des Chinidins. Dtsch. Arch. klin. Med.136, 181 (1921).

    Google Scholar 

  18. Bolton, F. G. andW. Damesiiek, Thrombocytopenic purpura due to quinidine. I.: Clinical studies. Blood11, 527 (1956).

    PubMed  Google Scholar 

  19. Breu, W. undS. Zollner, Chinidin als Antigen. Wien. Klin. Wschr.53, 524 (1940).

    Google Scholar 

  20. Briscoe, S. andJ. H. Burn, Quinidine and anticholinesterases on rabbit auricle. Brit. J. Pharmacol.9, 42 (1954).

    PubMed  Google Scholar 

  21. Brown, M. G., D. H. Holzman andE. W. Greelman, Serumquinidine concentration in congestive heart failure. Amer. J. Med. Sci.225, 129 (1953).

    PubMed  Google Scholar 

  22. Browning, R. J. andF. J. Heck, Fever secondary to ingestion of quinidine. Proc. Mayo Clin.35, 111 (1960).

    PubMed  Google Scholar 

  23. Brücke, F., Über herzwirksame Heilmittel mit Ausnahme der Digitalisstoffe. Verh. Dtsch. Ges. Kreislaufforschg.26, 29 (1960).

    Google Scholar 

  24. Cheng, T. O., Atrial flutter during quinidine therapy of atrial fibrillation. Amer. Heart J.52, 273 (1956).

    Article  PubMed  Google Scholar 

  25. Cheng, T. O., G. C. Sutton, W. P. Swisher andD. C. Sutton, Effect of quinidine on the ventricular complex of the electrocardiogram with special reference to the duration of theQ-T-interval. Amer. Heart J.51, 417 (1956).

    Article  PubMed  Google Scholar 

  26. Collins, D. C., Atypical secondary or symptomatic thrombocytopenic purpura developing with the use of quinidine sulfate. Circulation2: 438 (1950).

    PubMed  Google Scholar 

  27. Conn, H. L. andJ. C. Wood, Acute effects of quinidine on K-exchange and — distribution in the dog ventricle. Amer. J. Physiol.199, 151 (1960).

    PubMed  Google Scholar 

  28. Cookson, H., The etiology and prognosis of auricular fibrillation. Quart J. Med.23, 309 (1930).

    Google Scholar 

  29. De Graff, A. C. andC. Lingg, The course of rheumatic heart disease in adults. The influence of auricular fibrillation on the course of rheumatic heart disease. Amer. Heart J.10, 630 (1935).

    Article  Google Scholar 

  30. Dick, H. L. H., E. L. McCawley, D. V. Voiss andJ. D. Krueger, Electrocardiographic evaluation studies on quinidine induced change of myocardial conduction. Amer. Heart J.56, 396 (1958).

    Article  PubMed  Google Scholar 

  31. Di Palma, J. R. andJ. E. Schulz, Antifibrillatory drugs. Medicine29, 123 (1950).

    PubMed  Google Scholar 

  32. Edens, E., Die Krankheiten des Herzens und der Gefäße (Berlin-Göttingen-Heidelberg 1929).

  33. Efrati, P., Quinidine induced ventricular flutter successfully treated with procaine amide. Amer. J. Med.18, 348 (1955).

    Article  PubMed  Google Scholar 

  34. Ellek, S. R. andL. N. Katz, Further observation on the action of drugs on coronary vessel caliber. J. Pharmacol. Exper. Therap.75, 178 (1942).

    Google Scholar 

  35. Ells, H. A., R. Caputto andR. H. Furman, Metabolic properties of quinidine. Proc. Soc. Exper. Biol. Med.93, 189 (1956).

    Google Scholar 

  36. Fawaz, G., Effect of quinidine, procaine amide and mersalyl on lethal dose of ouabain in isolated dog heart. Proc. Soc. Exper. Biol. Med.88, 654 (1955).

    Google Scholar 

  37. Ferrer, M. I., R. M. Harvey, L. Werkö, D. T. Dresdale, A. Cournand andD. W. Richards, Some effects of quinidine sulfate on the heart and circulation in man. Amer. Heart J.36, 816 (1948).

    Article  Google Scholar 

  38. Ferreri, M. eA. Borghetti Asistolia completa ricorrente in corso di trattemento chinidinico. Giorn. Clin. Med.39, 899 (1958).

    Google Scholar 

  39. Finnegan, T. R. L. andJ. R. Trounce, Depression of the heart by quinidine and its treatment. Brit. Heart J.16, 341 (1954).

    PubMed  Google Scholar 

  40. Freedman, A. L., E. A. Brody andP.S. Barr, Immunothrombocytopenic purpura due to quinidine. Report of four new cases with special observations on patch testing. J. Lab. Clin. Med.48, 205 (1956).

    PubMed  Google Scholar 

  41. Freeman, I. andJ. Wexler, Anticoagulants for treatment of atrial fibrillation. Amer. Med. Acc.184, 1007 (1963).

    Google Scholar 

  42. Frey, W., Über Vorhofflimmern beim Menschen und seine Beseitigung durch Chinidin. Berl. Klin. Wschr.55, 450 (1918).

    Google Scholar 

  43. Friedberg, R. andB. Sjoestroem, Quinidine treatment of auricular fibrillation. Acta med. Scand.155, 293 (1956).

    PubMed  Google Scholar 

  44. Furman, R. H. andR. P. Howard, Metabolic effect of quinidine: Evidence suggesting impairment of glucose utilization. Amer. J. Med.19, 140 (1955).

    Article  Google Scholar 

  45. Gertler, M. M., J. Kream, J. W. Hylin, H. Robinson andE. G. Neidle, Effect of digoxin and quinidine on intracellular electrolytes of the rabbit heart. Proc. Soc. Exper. Biol. Med.92, 629 (1956).

    Google Scholar 

  46. Gittler, R. D., M. Kissin andJ. Litwins, Quinidine induced thrombocytopenic purpura complicating dicumarol therapy. Ann. Int. Med.42, 1118 (1955).

    PubMed  Google Scholar 

  47. Gold, H., Quinidine in disorders of the heart (New York 1950).

  48. Gold, H. andW. Modell, The action of quinidine on the heart in the normal unanesthetized dog. J. Pharmacol. Exper. Therap.46, 357 (1932).

    Google Scholar 

  49. Gonin, A., J. M. Barbier, S. Ithier, A. Perrin etR. Fromment, Arch. mal. coeur:51, 1144 (1958).

    PubMed  Google Scholar 

  50. Goodman, L. S. andA. Gilman, The pharmacological basis of therapeutics (New York 1958).

  51. Gordon, B., M. Matton andS. A. Levine, Mechanism of death from quinidine and method of resuscitation. Experimental study. J. Clin. Invest.1, 417 (1925).

    Google Scholar 

  52. Green, M., Periodic asystole following myocardial infarction and cardiac depressant drugs. Brit. Heart J.22, 734 (1960).

    PubMed  Google Scholar 

  53. Grisolia, S., The potentiating effect of digitoxin and quinidine on dinitrophenol uncoupling of oxydative phosphorylation. Biochim. Biophys. Acta18, 437 (1955).

    Article  PubMed  Google Scholar 

  54. Hall, H., Beitrag zur Behandlung des Vorhofflimmerns Acta med. Scand. Suppl.123, 162 (1941).

    Google Scholar 

  55. Halsey, J. T., C. Reynolds andS. N. Blackerg, Cardiac output in dogs as influenced by chloral, chloroform, quinidine, quinine, homocamfin, and ephedrin. J. Pharmacol. Exper. Therap.32, 89 (1927).

    Google Scholar 

  56. Hirsch, E. O. andW. Dameshek, Thrombocytopenic purpura due to allergy to quinidine. Study of the mechanism of thrombocytopenia. Amer. J. Med.9, 828 (1950).

    Article  PubMed  Google Scholar 

  57. Holland, W. C., A possible mechanism of action of quinidine. Amer. J. Physiol.190, 492 (1957).

    PubMed  Google Scholar 

  58. Holzman, D. andM. G. Brown, The use of quinidine in established auricular fibrillation and flutter. Amer. J. Med. Sci.222, 664 (1951).

    Google Scholar 

  59. Jackson, D. E., A. Friedlander andJ. V. Lawrence, An experimental investigation of the pharmacological action of quinidine. J. Lab. Clin. Med.7, 311 (1922).

    Google Scholar 

  60. Johnson, E. A. andM. G. McKinnon, The differential effect of quinidine and pyrilamine on the myocardial action potential at various rates of stimulation. J. Pharmacol. Exper. Therap.120, 460 (1957).

    Google Scholar 

  61. Kalamsohn, R. W. andJ. J. Sampson, Studies on plasma quinidine. II. Relation of toxic manifestations and therapeutic effects. Circulation1, 569 (1950).

    Google Scholar 

  62. Kerr, W. J. andW. L. Bender, Paroxysmal ventricular fibrillation with cardiac recovery in a case of auricular fibrillation with complete heart block while under quinidine. Heart9, 269 (1921).

    Google Scholar 

  63. Kissane, R. W., J. J. Conn andS. M. Rose, Atrial fibrillation reversion to normal sinus rhythm. Dis. Chest39, 299 (1961).

    PubMed  Google Scholar 

  64. Kohn, C. M. andS. A. Levine, An evaluation of the use of quinidine sulfate in persistent auricular fibrillation. Ann. Int. Med.8, 923 (1935).

    Google Scholar 

  65. Lee, Y. C., Quinidine intoxication. An experimental study of the effect of molar sodium lactate and potassium chloride. Amer. Heart J.60, 785 (1960).

    Article  PubMed  Google Scholar 

  66. Levy, R. L., Clinical studies of quinidine. IV. The clinical toxicity of quinidine. J. Amer. Med. Ass.79, 1102 (1923).

    Google Scholar 

  67. Lewis, T., The value of quinidine in cases of auricular fibrillation and methods of studying its clinical reactions. Amer. J. Med. Sci.163, 881 (1922).

    Google Scholar 

  68. Lindsetii-Ditlefsen, E. M., Quinidine concentration in blood and excretion in urine following parenteral administration as related to congestive heart failure. Acta med. Scand.159, 105 (1957).

    PubMed  Google Scholar 

  69. Lindsteth-Ditlefsen, E. M. andB. Knutsen, Quinidine treatment in chronic auricular fibrillation I. Conversion to sinus rhythm, related to quinidine serum concentration. Acta med. Scand.156, 1 (1956).

    Google Scholar 

  70. Linnenthal, A. J., B. M. Winer andM. I. Klayman, Sinoauricular nodal depression and atrio-ventricular nodal rhythm due to quinidine. Amer. Heart J.46, 443 (1953).

    Article  PubMed  Google Scholar 

  71. Liot, F., B. Coblentz, L. Scebat, H. Gras etJ. Lenègre, L'effet préventif de l'éphédrine sur les accidents syncopaux à le quinidine. (Etude de 300 cas de régularisation de fibrillation auriculaire). Arch. mal. coeur52, 1321 (1959).

    PubMed  Google Scholar 

  72. London, F. andM. Howell, Atrial flutter with 1 to 1 conduction during treatment with quinidine and digitalis. Amer. Heart J.48, 152 (1954).

    Article  PubMed  Google Scholar 

  73. Love, W. D., The basis of quinidine therapy. Amer. J. Med. Sci.229, 89 (1955).

    PubMed  Google Scholar 

  74. Maurice, P., J. Acar, R. Rullière etJ. Lenègre, Traitement par la quinidine de 390 cas de fibrillation auriculaire. Arch. mal. coeur49, 615 (1956).

    PubMed  Google Scholar 

  75. Möckel, E. undJ. Seusing, Thrombocytopenische Purpura bei Chinidinüberempfindlichkeit. Ärztl. Wschr.9, 876 (1955).

    Google Scholar 

  76. Morpurgo, M. undG. Mars, Neue klinische und pharmakologische Erfahrungen mit Chinidin. Arztl. Forschg.12, 435 (1950).

    Google Scholar 

  77. Morpurgo, M., G. Mars etB. Severgnini, Données électromécaniques et hémodynamiques en faveur du traitement quinidinique dans les cardiopathies séniles. Arch. mal. coeur.49, 938 (1956).

    PubMed  Google Scholar 

  78. Parkinson, J. andM. Campbell, Quinidine treatment of auricular fibrillation. Quart. J. Med.22, 281 (1929).

    Google Scholar 

  79. Petter, A. undK. Zipf, Zur antifibrillären Herzwirkung von Ajmalin, Chinidin und Novocainamid. Arch. exper. Path. Pharm.234, 519 (1962).

    Google Scholar 

  80. Rainier-Pope, C. R., V. Schrire, W. Beck, andC. N. Barnard, The treatment of quinidine induced ventricular fibrillation by closed chest resuscitation and external defebrillation. Amer. Heart J.63, 582 (1962).

    Article  Google Scholar 

  81. Renais, J., P. Maurice, L. Scebat etJ. Lenègre, Etude de la quinidinémie au cours de 127 tentative de régularisation de fibrillation ou de flutter auriculaire. Arch. mal. coeur51, 1132 (1958).

    PubMed  Google Scholar 

  82. Robbin, S. R. andE. S. Cohen, Quinidine therapy for atrial fibrillation. Indications and toxic effects. Amer. J. Cardiol.1, 629 (1958).

    Article  PubMed  Google Scholar 

  83. Robbin, S. R., S. Goldstein, M. F. Schwartz undS. Dack, Adams-Stokes-Syndrome. Amer. J. Med.18, 577 (1955).

    Article  PubMed  Google Scholar 

  84. Rodensky, P. L., J. H. Kathe andF. Wasserman, The effect of quinidine on tolerance to digoxin. Amer. J. Cardiol.5, 498 (1960).

    Article  PubMed  Google Scholar 

  85. Rose, O. A., A. Vogel andA. I. Trutz, Drug fever due to quinidine. New Engl. J. Med.248, 96 (1953).

    PubMed  Google Scholar 

  86. Rothman, S. andW. C. Yang, Mechanism of negative chronotropic and inotropic effects of some antifibrillatory agents. Amer. J. Physiol.206, 283 (1964).

    PubMed  Google Scholar 

  87. Rotschild, M. A. andS. Furman, Electrocardiographie changes after quinidine in supraventricular tachycardia. Amer Heart J.46, 918 (1953).

    Article  PubMed  Google Scholar 

  88. Rowe, G. G., D. A. Emanuel, G. A. Maxwell, J. F. Brown, C. Castillo, B. Schuster, Q. R. Murphy andC. W. Crumpton, Hemodynamic effects of quinidine; including studies of cardiac work and coronary output. J. Clin. Invest.36, 844 (1951).

    Google Scholar 

  89. Sagall, E. L., C. D. Horn andJ. E. Riseman, Studies on the action of quinidine in man. I. Measurement of the speed and duration of the effect following oral and intramuscular administration. Arch. Int. Med.71, 460 (1943).

    Google Scholar 

  90. Schen, R. J. andM. Rabinowitz, Thrombocytopenic purpura due to quinidine. Brit. Med. J. II, 1502 (1958).

    Google Scholar 

  91. Schott, A., Behandlung von Vorhofflattern und-flimmern. Verh. Dtsch. Ges. Kreislaufforschg.26, 224 (1960).

    Google Scholar 

  92. Selzer, A. andH. W. Wray, Quinidine syncope. Paroxysmal ventricular oscillation occuring during treatment of chronic atrial arrhythmias. Circulation30, 17 (1964).

    PubMed  Google Scholar 

  93. Shaffel, N. andA. Halpern, The quinidin problem. Angiology9, 34 (1958).

    PubMed  Google Scholar 

  94. Shulman, N. R., Immunoreaction involving platelets. IV. Studies on the pathogenesis of thrombocytopenia in drug purpura using test doses of quinidine in sensitized individuals; their implications in idiopathic thrombocytopenic purpura. J. Exper. Med.107, 711 (1958).

    Article  Google Scholar 

  95. Sierra, M. A., A. H. Keyes, R. M. Williams, D. J. Becker, C. W. Silverblatt, R. Gardner andF. Wasserman, The effects of 2-amino-2-hydroxymethyl 1,3 proponediol (THAM) in experimental quinidine intoxication. Amer. J. Cardiol.10, 562 (1962).

    Article  PubMed  Google Scholar 

  96. Smith, F. J. andN. E. Clarke, Quinidine in the treatment of auricular fibrillation, established, paroxysmal and transient. Arch. Int. Med.36, 838 (1925).

    Google Scholar 

  97. Smith, F. H., C. G. Eachern andG. E. Hall, The effect of the intravenous administration of quinidine sulfate on the development of ventricular fibrillation following sudden occlusion of the circumflex branch of the left coronary artery. Amer. Heart J.20, 620 (1940).

    Article  Google Scholar 

  98. Sokolow, M., Some quantitative aspects of the treatment with quinidine. Ann. Int. Med.45, 582 (1950).

    Google Scholar 

  99. Sokolow, M., Present status of therapy of the cardiac arrhythmias with quinidine. Amer. Heart J.42, 771 (1951).

    Article  PubMed  Google Scholar 

  100. Sokolow, M. andA. L. Edgar, Blood quinidine concentration as a guide in the treatment of cardiac arrhythmias. Circulation1, 576 (1950).

    Google Scholar 

  101. Spang, K., Rhythmusstörungen des Herzens (Stuttgart 1957).

  102. Spielmann, W., A. Gathof, W. Fritsche undE. F. Pfeiffer, Über die Bedeutung der serologischen Reaktionen bei allergisch-medikamentös bedingten Thrombopenien, dargestellt an einem Fall von Chinidinpupura. Acta haematol.17, 287 (1957).

    PubMed  Google Scholar 

  103. Sprague, H. B. andW. A. Tansey, Fever as a sign of quinidine toxicity. Report of sensitivity in two brothers with thyroid disease. New Engl. J. Med.249, 798 (1953).

    PubMed  Google Scholar 

  104. Starr, I., C. J. Gamble, A. Margolies, J. S. Donal, N. Joseph andE. Eagle, A clinical study of the action of ten commonly used drugs on cardiac output, work and size; on respiration, on metabolic rate, and on the electrocardiogram. J. Clin. Invest.16, 799 (1937).

    Google Scholar 

  105. Stein, E., P. Schölmerich undM. Dohmen, Über Ursachen und Häufigkeit der arteriellen Embolie. Verh. Dtsch. Ges. Inn. Med.67, 302 (1961).

    Google Scholar 

  106. Stepp, W. undL. L. Kirchmann, Über Versuche mit Chinidin-Sympatol zur Behandlung des Vorhofflimmerns. Münch. Med. Wschr.86, 433 (1939).

    Google Scholar 

  107. Stimson, W. H. andV. A. McKusick, Febrile reactions to quinidine. Amer. J. Med. Sci.221, 440 (1951).

    PubMed  Google Scholar 

  108. Szekeres, L. andG. Lenard, Paradoxical effect of quinidine upon coronary flow of the isolated heart at different temperatures. Experientia14, 338 (1958).

    PubMed  Google Scholar 

  109. Taylor R. andR. Potashnick, Quinidine-induced exfoliative dermatitis with a brief review of quinidine idiosyncrasis. J. Amer. Med. Ass.145, 641 (1951).

    Google Scholar 

  110. Thomson, G. W., Quinidine as a cause of sudden death. Circulation14, 757 (1956).

    PubMed  Google Scholar 

  111. Uyeki, E. M., E. M. K. Geiling andK. P. Dubois, Studies on the effect of quinidine on intermediary carbohydrate metabolism. Arch. intern. Pharmacodynamic97, 191 (1951).

    Google Scholar 

  112. Vaughan, Williams, E. M., zit. n.Brücke, Brit. J. Pharmacol.13, 276 (1958).

    PubMed  Google Scholar 

  113. Viko, L. E., H. M. Marvin andP. D. White, A clinical report on the use of quinidine sulfate. Arch. Intern. Med.31, 345 (1923).

    Google Scholar 

  114. Wasserman, F., L. Brodsky, M. M. Dick, J. H. Kathe andP. L. Rodensky, Succesful treatment of quinidine and procaine amide intoxication. Report of three cases. New Engl. J. Med.259, 797 (1958).

    PubMed  Google Scholar 

  115. Wasserman, F., L. Brodsky, J. H. Kathe, P. L. Rodensky, M. M. Dick andP. S. Denton, The effect of molar sodium lactate in quinidine intoxication. An experimental study. Amer. J. Cardiol.3, 294 (1959).

    Article  PubMed  Google Scholar 

  116. Wechsler, H. L., Dermatitis medicamentosa; a lichen planus like erythema due to quinidine. Arch. Dermat. and Syph.69, 741 (1954).

    Google Scholar 

  117. Wegria, R. andM. N. Boyle, Correlation between the effect of quinidine sulfate on the heart and its concentration in the blood plasma. Amer. J. Med.4, 379 (1948).

    Google Scholar 

  118. Wegria, R. andN. D. Nickerson, Effect of papaverine, epinephrine, and quinidine on fibrillation threshold of mammalian ventricles. J. Pharmacol. Exper. Therap.75, 50 (1942).

    Google Scholar 

  119. Weidman, S., The effect of the cardiac membrane potential on the rapid availability of the sodium carrying system. J. Physiol.127, 213 (1955).

    PubMed  Google Scholar 

  120. Weinberg, S. J. andT. J. Haley, Centrally mediated effects of cardiac drugs. Strophantin-K quinidine and procaine amide. Circulation Res.3, 103 (1955).

    PubMed  Google Scholar 

  121. Weisman, S. A., Study of the analeptic value of certain drugs in the treatment of quinidine depression. Amer. Heart J.24, 240 (1942).

    Article  Google Scholar 

  122. Weisman, S. A., Quinidine, “pure Quinidine”, and Hydroquinidine. Amer. Heart J.24, 545 (1942).

    Article  Google Scholar 

  123. Weisman, S. A., Review and evaluation of quinidine therapy for auricular fibrillation. J. Amer. Med. Ass.152, 496 (1953).

    Google Scholar 

  124. Wetherbee, D. C., D. Holzman andM. G. Brown, Ventricular tachycardia following quinidine. Amer. Heart J.43, 89 (1952).

    Article  PubMed  Google Scholar 

  125. Wick, E. undJ. Dörner, Experimentelle Studien zum Herzinfarkt. Die Beeinflussung der extrasystolischen Kammertachykardie und der Kontraktionskraft des Hundeherzens durch hohe Dosen Chinidin bei chronischer peroraler Verabreichung. Verh. Dtsch. Ges. Kreislaufforschg.25, 294 (1959).

    Google Scholar 

  126. Yount, E. A., M. Rosenblum andR. L. McMillan, The use of quinidine in the treatment of chronic auricular fibrillation. Arch. Int. Med.89, 63 (1952).

    Google Scholar 

  127. Zeh, E. undE. Glöckler, Vergleichende experimentelle Untersuchungen über die Toxizität von Novocainamid und Chinidin in Verbindung mit Strophanthin. Ärztl. Forschg.13, 253 (1959).

    Google Scholar 

  128. Zohmann B. L. et al., Quinine and quinidine sulfate as coronary vasodilatators. Circulation12, 793 (1955).

    Google Scholar 

Download references

Author information

Author notes

  1. P. Schollmeyer

    Present address: Medizinischen Universitätsklinik Tübingen, 74, Tübingen

  2. E. Stein

    Present address: , Salzdahlumer Str. 90, 33, Braunschweig

Authors and Affiliations

  1. Medizinischen Universitätsklinik Tübingen, 74, Tübingen

    E. Stein

Authors
  1. E. Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Schollmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Mit 5 Abbildungen in 14 Einzeldarstellungen und 2 Tabellen

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stein, E., Schollmeyer, P. Zwischenfälle bei Chinidinbehandlung. Archiv für Kreislaufforschung 53, 70–93 (1967). https://doi.org/10.1007/BF02119714

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02119714

Search

Navigation